tradingkey.logo
tradingkey.logo

Vivani Medical Announces Rapid Advancement Of NPM-139

ReutersAug 5, 2025 1:25 PM

- Vivani Medical Inc VANI.O:

  • VIVANI MEDICAL ANNOUNCES RAPID ADVANCEMENT OF NPM-139, A NOVEL SEMAGLUTIDE IMPLANT, FOLLOWING POSITIVE WEIGHT LOSS DATA FROM AN ONGOING PRECLINICAL STUDY OF NPM-139 AND PROMISING RESULTS FROM THE LIBERATE-1 PHASE 1 CLINICAL STUDY OF NPM-115

  • VIVANI MEDICAL INC - PRIORITIZES ADVANCEMENT OF NPM-139, WITH CLINICAL DEVELOPMENT EXPECTED TO BEGIN IN 2026

  • VIVANI MEDICAL- NEW NPM-139 PRECLINICAL FEASIBILITY DATA SHOWED ABOUT 20% WEIGHT LOSS MAINTAINED LONGER THAN 6 MONTHS WITH A SINGLE IMPLANT

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI